Purpose of this Study
We are doing this study to learn more about how certain vaccines can affect people's polyethylene glycol (PEG) sensitivity levels. PEG is a component of several different vaccines. We want to compare blood samples from healthy volunteers to blood samples from HIV Vaccine Trials Network (HVTN) 133 participants. We hope this will help us better understand the variation of PEG sensitivity in the general population and between vaccinated and unvaccinated individuals.
Who Can Participate?
Eligibility
Adults ages 18-50 who:
- Are in general good health
- Are not pregnant or breastfeeding
- Do not use any medications that can suppress the immune system
Age Range
18-50
Sex/Genders
Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
Yes
What is Involved?
Description
If you choose to join this study, you will:
- Visit our clinic up to 3 times over the course of about a month
- Have a blood draw at each visit
Locations
Other
Visit Timing
Weekdays
Compensation
Yes
Spanish Materials Available
No
Study Details
Full Title
Assessing polyethylene glycol (PEG) sensitivity in participants enrolled in HVTN 133 and a healthy control population
Principal Investigator
Emmanuel
Walter
Protocol Number
PRO00116401
NCT ID
NA
Phase
N/A
Enrollment Status
Open to Enrollment